$34.74
-0.05 (-0.14%)
Performance
1D
—
1W
—
1M
—
3M
-8.46%
6M
+7.02%
1Y
+622.25%
YTD
+0.00%
Open$34.94
Previous Close$34.79
Day High$35.40
Day Low$34.47
52W High$43.73
52W Low$4.55
Volume—
Avg Volume1.53M
Market Cap5.94B
P/E Ratio—
EPS$-2.55
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$37.85
Below
SMA 200
$20.09
Above
RSI (14)
53
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+141.7% upside
Current
$34.74
$34.74
Target
$83.97
$83.97
$51.90
$83.97 avg
$108.57
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.66B | 1.76B | 1.56B |
| Net Income | -282,006,496 | -354,880,166 | -268,142,716 |
| Profit Margin | -17.0% | -20.2% | -17.2% |
| EBITDA | -474,772,680 | -496,954,417 | -453,512,070 |
| Free Cash Flow | -249,995,996 | -301,722,393 | -268,935,506 |
| Rev Growth | -0.8% | +1.9% | -1.2% |
| Debt/Equity | 0.59 | 0.54 | 0.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |